CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Finds
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently rejected.
your-feed-healthcare
CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Finds
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently rejected.
CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Finds
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently rejected.
CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Finds
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently rejected.
CVS, Walgreens and Walmart Fueled Opioid Crisis, Jury Finds
This is the first jury verdict in an opioid case. The decision embraced a key legal argument that judges in other opioid cases had recently rejected.
CVS, Walgreens and Walmart Perpetuated Opioid Crisis, Jury Finds
This is the first jury verdict in an opioids case. The decision embraced a key legal argument that judges in other opioids cases had recently rejected.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
How Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
How Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen
Too often, seniors who use opioids become targets for exploitation and abuse.
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen
Too often, seniors who use opioids become targets for exploitation and abuse.
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen
Too often, seniors who use opioids become targets for exploitation and abuse.
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen
Too often, seniors who use opioids become targets for exploitation and abuse.
The Pain Wouldn’t Stop — Because Her Medication Had Been Stolen
Too often, seniors who use opioids become targets for exploitation and abuse.
Phony Diagnoses Hide High Rates of Drugging at Nursing Homes
At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.
Phony Diagnoses Hide High Rates of Drugging at Nursing Homes
At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.
Ivermectin Won’t Treat Covid-19 but Demand for Drug Surges
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
Ivermectin Demand Surges Though It Doesn’t Work for Covid-19
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.
Ivermectin Demand Surges Though It Doesn’t Work for Covid-19
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.
Drug Distributors and Johnson & Johnson Reach $26 Billion Deal to End Opioid Suits
The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services.
Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioids Lawsuits
The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services.
States and Cities Near Tentative $26 Billion Deal in Opioids Cases
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.
How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
States and Cities Near Tentative $26 Billion Deal in Opioids Cases
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.
How an Unproven Alzheimer’s Drug Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
Cleveland Clinic Says It Won’t Administer Aduhelm to Patients
The major medical center’s rejection of the new Alzheimer’s drug is one of the starkest signs of concern over its effectiveness.
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
15 States Reach a Deal With Purdue Pharma Over Opioids
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
15 States Reach a Deal With Purdue Pharma, Moving Toward a $4.5 Billion Opioids Settlement
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.
Desperate for Covid Care, Undocumented Immigrants Resort to Unproven Drugs
Shut out from mainstream medicine, some immigrants are buying expensive, unproven Covid therapies from “wellness” clinics or turning to the black market.
A Pill to Treat Covid-19? The U.S. Is Betting on It.
A new $3.2 billion program will support the development of antiviral pills, which could start arriving by the end of this year.
A Pill to Treat Covid-19? The U.S. Is Betting on It.
A new $3.2 billion program will support the development of antiviral pills, which could start arriving by the end of this year.
F.D.A. Still Lacks a Permanent Commissioner
With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.
F.D.A. Still Lacks a Permanent Commissioner
With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.
Biogen’s Alzheimer’s Drug Poses a Dilemma for the F.D.A.
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
Alzheimer’s Drug Poses a Dilemma for the F.D.A.
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
Alzheimer’s Drug Poses a Dilemma for the F.D.A.
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
Coronavirus Pandemic Forces FDA to Sharply Curtail Drug Company Inspections
The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections
The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
How Merck, a Vaccine Titan, Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
La búsqueda de tratamientos contra la COVID-19 quedó rezagada
El desarrollo de las vacunas superó las expectativas de todos. Pero durante los próximos meses muchas personas enfermarán y, lamentablemente, los médicos tienen pocos fármacos para tratarlas.
La búsqueda de tratamientos contra la COVID-19 quedó rezagada
El desarrollo de las vacunas superó las expectativas de todos. Pero durante los próximos meses muchas personas enfermarán y, lamentablemente, los médicos tienen pocos fármacos para tratarlas.
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead
Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead
Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.
Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease
Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.
Pregnant Women Get Conflicting Advice on Covid-19 Vaccines
The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.
Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
Pfizer Will Ship Fewer Vaccine Vials to Account for ‘Extra’ Doses
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
U.S. Vaccine Supply: What to Know
Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?
Why Biden Inherited a Covid-19 Vaccine Supply Unlikely to Grow Before April
But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.
Biden Inherits a Vaccine Supply Unlikely to Grow Before April
But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.
U.S. Vaccine Supply: What to Know
Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?
U.S. Vaccine Supply: What to Know
Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?
Covid Deaths Lowered in Trial of Tocilizumab and Sarilumab
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.
Covid Deaths Lowered in Trial of Tocilizumab and Sarilumab
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.
Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Don’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
Don’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
Why Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
What You Need to Know About the Covid Drugs That Could Help Many
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
What to Know of Covid-19 Antibody Drugs: Cost, Availability and More
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
F.D.A. Clears Moderna’s Covid Vaccine
The Food and Drug Administration authorized a second coronavirus vaccine for emergency use, clearing the way for millions more Americans to be immunized next week.
What People With Allergies Should Know About Covid Vaccines
Four people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine. Experts say that shouldn’t deter most people from getting a jab.
States Complain of Smaller Covid Vaccine Shipments Than Expected
The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.
States Complain of Smaller Covid Vaccine Shipments Than Expected
The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.
States Complain of Smaller Vaccine Shipments Than Expected
The smaller number of expected doses, which appeared to be the result of a scheduling hiccup, reignited tensions between the federal government and Pfizer over vaccine supply.
F.D.A. Panel Endorses Moderna’s Coronavirus Vaccine
An advisory group’s recommendation will mean millions more Americans can be inoculated, extending protection against Covid beyond big urban areas into rural and suburban regions.
Vacuna de Moderna contra el coronavirus: lo que necesitas saber
La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.
Vacuna de Moderna contra el coronavirus: lo que necesitas saber
La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.
La vacuna de Moderna tiene altos índices de protección contra el coronavirus. ¿Cómo es distinta de la vacuna de Pfizer-BioNTech?
La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
The positive review likely ensures that the F.D.A. will approve a second coronavirus vaccine this week for millions of Americans.
Covid Patient Study Shows Some Benefit From an Arthritis Drug
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Covid Patient Study Shows Some Benefit From an Arthritis Drug
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Covid Patient Study Shows Some Benefit From an Arthritis Drug
Baricitinib had previously attracted some scrutiny from experts, who were unsure when it would most help their patients.
Pfizer’s Covid Vaccine and Allergies: How Concerned Should You Be?
British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.
Moderna to Begin Testing Its Coronavirus Vaccine in Children
The company said the trial would involve children ages 12 through 17.
CVS to Give Out Covid-19 Treatment in Nursing Homes
The three-month pilot program involves just 1,000 doses of the medication in seven big cities. It’s not clear how much impact that will have as demand surges.
Moderna Applies for Emergency F.D.A. Approval for Its Coronavirus Vaccine
The first shots could be given as early as Dec. 21, if authorization is granted.
Pfizer Applies for Emergency F.D.A. Approval for Covid-19 Vaccine
A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages.
F.D.A. Grants Emergency Authorization of Antibody Treatment Given to Trump
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
English
Afrikaans
Shqip
አማርኛ
العربية
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
简体中文
繁體中文
Corsu
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Filipino
Suomi
Français
Frysk
Galego
ქართული
Deutsch
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
हिन्दी
Hmong
Magyar
Íslenska
Igbo
Bahasa Indonesia
Gaelige
Italiano
日本語
Basa Jawa
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
한국어
كوردی
Кыргызча
ພາສາລາວ
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Bahasa Melayu
മലയാളം
Maltese
Te Reo Māori
मराठी
Монгол
ဗမာစာ
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
سنڌي
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
தமிழ்
తెలుగు
ไทย
Türkçe
Українська
اردو
O‘zbekcha
Tiếng Việt
Cymraeg
isiXhosa
יידיש
Yorùbá
Zulu